In contrast to constitutive PD-L1 expression by tumor cells due to CD274 amplification, PD-L1 was induced in tumors and infiltrating immune cells in EBV (+) GC in response to adaptive immune resistance. The gene discussed is CD274; the disease is neoplasm.